Genesis Biopharma Names Michael Handelman as CFO and Treasurer
Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has named Michael Handelman as chief financial officer (CFO), treasurer and secretary, succeeding Richard McKilligan.
Handelman currently serves as the CFO of Oxis International. Before joining Oxis, he served as CFO and chief operating officer (COO) of TechnoConcepts, a developing technology and manufacturing company. Prior to that, he was CFO of Interglobal Waste Management, a start-up manufacturing company. Handelman has also been CFO of the Los Angeles Kings, a National Hockey League franchise. He is a certified public accountant (CPA) and holds a degree in accounting from the City University of New York.